Amyloid cardiomyopathy is a disease caused by the buildup of misfolded proteins on the heart muscle. Left untreated, it can be deadly. But many patients receive a diagnosis only in its later stages, after the onset of dangerous complications such as heart failure.
Now, Yale scientists have built an AI platform that doctors can access from their smartphones. It screens for the condition using images from electrocardiograms (ECG), a noninvasive test that measures the heart’s electrical activity. The platform—described recently in JAMA—can help doctors detect the disease more quickly and intervene before extensive heart damage occurs.